PLK4 has been found overexpressed in BC of all subtypes and its increased activity has been consistently linked to disease aggressiveness and epithelial–mesenchymal transition in vitro and in vivo.97, 98, 99, 100, 101. Here, PLK4 is linked to breast cancer.